Skip to main content
Clinical Trials/CTIS2023-504340-34-01
CTIS2023-504340-34-01
Active, not recruiting
Phase 1

Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE)

Wellbeing Services County Of North Karelia Siun Sote0 sites534 target enrollmentOctober 15, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Wellbeing Services County Of North Karelia Siun Sote
Enrollment
534
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 15, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Wellbeing Services County Of North Karelia Siun Sote

Eligibility Criteria

Inclusion Criteria

  • Age \= 18 years, informed written consent, at least one major or two minor bleeding risk criteria of Academic Research Consortium (ARC). Either of the following: Stabile angina or dyspnea and a coronary narrowing causing myocardial ischemia detected in the angiogram. In stable patients prior PCI, the evidence of ischemia is needed acquired either by perfusion imaging or by pressure wire measurement (FFR) during coronary angiography unless the coronary stenosis is \> 90% in diameter. ACS (UAP or NSTEMI): symptoms of heart ischemia\= 20 minutes and \= 0,5mm ST\-depression or transient ST\-elevation or T\-wave inversion at least in two adjacent leads and/or a high sensitivity troponin (hs\-tnt) rise at least one unit above the 99\. percentil or at least 50% rise in hs\-tnt between two samples taken 1\-3 hours apart. At least one of the following: \=1 de novo lesions in native coronary arteries or bypass vein grafts. Reference diameter of the vessel is 2\.0\-5\.0mm. Lesion length \= 40mm. Lesion or lesions are suitable for PCI.

Exclusion Criteria

  • Inability to give written consent STEMI. Reference diameter of the vessel is \<2\.0mm or \>5\.0 mm. Bifurcation lesion requiring the stenting of either of the branches after predilatation. (TIMI\<3 or significant recoil \>30% in the main epicardial vessel: LAD, LCX or RCA) after predilatation). Dissection affecting the flow (TIMI\<3\) or significant recoil (\>30% in the main epicardial vessel: LAD, LCX or RCA) after predilatation. In\-stent restenosis. Chronic total occlusion. Life expectancy \< 12 months. Cardiogenic shock at the arrival to the coronary angiography. Uncertainty about neurological recovery e.g. after resuscitation. Need for bypass surgery by heart team decision.

Outcomes

Primary Outcomes

Not specified

Similar Trials